Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Sun Pharma Q1 net rises 27% to ₹2,895 crore
Sun Pharmaceuticals Industries Ltd. for the first quarter ended June 30, 2026 reported a 27% year-n-year growth in consolidated net profit to ₹2,895 crore. Sales income at ₹15,184 crore grew 10.1%. Global Innovative Medicines sales at…
Amundi Increases Stake in Royalty Pharma PLC $RPRX
Amundi boosted its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 15.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,088,773…
Sun Pharma on track to complete Organon transaction by Q4, says management
Sun Pharmaceutical Industries Ltd expects to complete its $11.75 billion acquisition of US-based Organon in the fourth quarter of financial year 2027, top management with the drugmaker said, after the company shared its financial performance for…
Sun Pharma posts higher quarterly profit on strong demand
Sun Pharmaceutical Industries reported a 27 per cent rise in quarterly profit on Friday, boosted by strong demand for its high-margin specialty medicines used to treat chronic and complex conditions. Consolidated net profit rose to ₹2,895…
Torrent Pharma to cut medical representative strength to around 9,000 this year
Torrent Pharmaceuticals, the flagship entity of Gujarat-based Torrent Group, plans to reduce its medical representative (MR) strength to around 9,000 from the current combined field force of 9,400 as it integrates the operations of JB Chemicals &…
Strides Pharma Science Q1 PAT rises 56.7% to ₹165.5 cr
Strides Pharma Science Ltd on Friday reported a 56.7 per cent rise in profit after tax at Rs 165.5 crore in the first quarter ended June 30, on the back of strong growth in markets excluding the US. The company had posted a profit after tax of Rs…
Pfizer (NYSE: PFE) Offers Value And Income While Eli Lilly (NYSE: LLY) Bets On Growth In Diverging Pharma Investment Race
Pfizer (NYSE: PFE) and Eli Lilly and Company (NYSE: LLY) represent two sharply different investment cases within the pharmaceutical sector, appealing to entirely different types of investors. Pfizer has seen its valuation compress significantly in…
Vestor Capital LLC Acquires 71,688 Shares of Royalty Pharma PLC $RPRX
Vestor Capital LLC boosted its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 597.4% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 83,688 shares of the…
Summit Therapeutics: Upgrading To Hold As Critical Approval Decision Approaches (SMMT)
Summit Therapeutics Inc. is upgraded from Sell to Hold as the FDA reviews its BLA for ivonescimab, with a decision expected by November 14, 2026. SMMT's pivotal HARMONI study showed statistically significant PFS but only a favorable trend in OS;…
XLV vs. IHE: Which Healthcare ETF Is the Better Buy?
The State Street Health Care Select Sector SPDR ETF (XLV -0.44%) provides broad healthcare exposure at a lower cost, while the iShares U.S. Pharmaceuticals ETF (IHE -0.91%) offers a concentrated bet on U.S. drugmakers. While both funds target…
Sensex gains 274 points, Nifty ends above 24,300
17:01 Domestic benchmark equity indices closed higher on Thursday amid mixed sectoral performance with bargain hunting driving a broad-based rally led by IT and auto. The Sensex closed in the green at 77,928.15, up 273.55 points or 0.35 per cent…
Blackstone Mortgage Trust: Downgrade After Q2 Miss, Loan Growth And Performance Impress
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
CM presents Telangana as safe, strategic investment destination
Chief Minister A. Revanth Reddy has invited industry leaders to invest in Telangana, describing the State as one of the country's most strategic and secure investment destinations. Addressing representatives of the Confederation of Indian Industry…
Nabil Saba on ASCO's New Guideline on Treatment of Thyroid Cancer
This Reading Room is a collaboration between MedPage Today and: Although treatment advances for thyroid cancer have reshaped the management landscape and improved disease control, they have also raised new questions and considerations for…
Teva Pharmaceutical Industries Ltd. $TEVA Stake Boosted by Avidity Partners Management LP
Avidity Partners Management LP increased its holdings in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 7.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission.
Receive a Daily briefing on Pharma Industry News
Get Started